You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Medtronic
Baxter
McKinsey

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Litigation Details for AMGEN INC. v. PRICE (D.C. 2017)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

AMGEN INC. v. PRICE (D.C. 2017)

Docket   Start Trial Date Filed 2017-05-25
Court District Court, District of Columbia Date Terminated
Cause 05:0706 Judicial Review of Agency Actions Assigned To Randolph Daniel Moss
Jury Demand None Referred To
Parties ALEX M. AZAR, II; AMGEN INC.; AMNEAL PHARMACEUTICALS LLC; BARR LABORATORIES, INC.; SCOTT GOTTLIEB; TEVA PHARMACEUTICALS USA, INC.; THOMAS E. PRICE; WATSON LABORATORIES, INC.
Patents 6,011,068
Attorneys Brian Burgess; Catherine Emily Stetson; Charles John Biro; Douglas B. Farquhar; Jennifer McVey Thomas; Joshua James Bone; Kurt R. Karst; Prescott Moore Lassman; Susan Margaret Cook; William M. Jay
Firms Goodwin Procter LLP; Hogan Lovells US LLP; Hyman, Phelps & McNamara, P.C.; U.S. Department of Justice
Link to Docket External link to docket
Small Molecule Drugs cited in AMGEN INC. v. PRICE
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for AMGEN INC. v. PRICE (D.C. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-05-25 1 NSiPAR, U.S. Patent No. 6,011,068 (the ‘068 Patent), is due to expire on March 8, 2018. As a result, the … of 33 existing patent rights 21 U.S.C. § 355a(b)(2), (c)(2). One ofthe key patents covering Sf€NSiPAR…exclusivity and patent-related protections After any such periods of exclusivity and patent protections expire…and patent protection automatically applies Id. at §§ 355a(b)(l), (c)(l) (exclusivities and patent protection…of’ the underlying patent exclusivity ld. §§ 355a(b)(2), (c)(2). Because a key patent covering SENSIPAR External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Mallinckrodt
Harvard Business School
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.